AAP Immunization Coding Table
For the Immunization Schedules, visit Red Book Online
Updated October 2024
Vaccine Products
Separately report the administration with appropriate CPT code(s)
CPT Code Descriptor Manufacturer Brand # of Components
90589 Chikungunya virus vaccine, live attenuated, for IM use Valneva VLA1553 1
90700 Diphtheria tetanus toxoids, and acellular pertussis vaccine (DTaP), when SP DAPTACEL 3
administered to <7 years, for IM use GSK Infanrix
90702 Diphtheria and tetanus toxoids (DT), adsorbed when administered to SP Diphtheria and TETANUS 2
younger than seven years, for IM use TOXOIDS Adsorbed
90696 Diphtheria, tetanus toxoids, and acellular pertussis vaccine GSK KINRIX
and inactivated poliovirus vaccine (DTaP-IPV), when SP Quadracel 4
administered to children 4-6 years of age, for IM use
90697 Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated Merck VAXELIS
poliovirus, haemophilus Influenza type b PRP-OMP conjugate, and SP 6
hepatitis B vaccine (DTaP-IPV-Hib-HepB), for IM use
90723 Diphtheria, tetanus toxoids, acellular pertussis, Hepatitis GSK Pediarix
B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for 5
IM use
90698 Diphtheria, tetanus toxoids, acellular pertussis, haemophilus Influenza SP Pentacel 5
Type B, and inactivated poliovirus vaccine (DTaP-IPV/Hib), for IM use
90633 Hepatitis A vaccine (HepA), pediatric/adolescent dosage, 2 dose, for IM GSK Haxrix 1
use Merck VAQTA
90740 Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient Merck Recombivax HB 1
dosage, 3 dose, for IM use
90743 Hepatitis B vaccine (HepB), adolescent, 2 dose, for IM use Merck Recombivax HB 1
90744 Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose, for IM Merck Recombivax HB 1
use GSK Energix-B
90746 Hepatitis B vaccine (HepB), adult dosage, for IM use Merck Recombivax HB 1
GSK Energix-B
90747 Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient GSK Energix-B 1
dosage, 4
dose, for IM use
90647 Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 Merck PedvaxHIB 1
dose, for IM use
90648 Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose, SP ActHIB 1
for IM use GSK Hiberix
90651 Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, Merck Gardasil 9 1
nonavalent (9v HPV), 2 or 3 dose schedule, for IM use
90707 Measles, mumps, and rubella virus vaccine (MMR), live, for SQ use Merck M-M-R II 3
GSK PRIORIX
90710 Measles, mumps, rubella, and varicella vaccine (MMRV), live, for SQ use Merck ProQuad 4
90619 Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, SP MenQuadfi 1
TETANUS TOXOIDS carrier (MenACWY-TETANUS TOXOIDS), for IM
use
90620 Meningococcal recombinant protein and outer membrane vesicle GSK Bexsero 1
vaccine, serogroup B (MenB-4C), 2 dose schedule, for IM use
90621 Meningococcal recombinant lipoprotein vaccine, serogroup B, 2 Pfizer TRUMENBA 1
or 3 dose schedule, for IM use
90734 Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, GSK Menveo 1
diphtheria toxoid carrier, (MenACWY-D) or CRM197
carrier(MenACWY-CRM), for IM use
90623 Meningococcal pentavalent vaccine, conjugated Men A, C, W, Y- tetanus Pfizer PENBRAYA 1
toxoid carrier, and Men B-FHbp, for IM use
90732 Pneumococcal polysaccharide vaccine, 23-valent (PPSV23), adult or Merck Pneumovax 23 1
immunosuppressed patient dosage, when administered to 2 years or
older, for subcutaneous or IM use
90671 Pneumococcal conjugate vaccine, 15 valent (PCV15), for IM use Merck VAXNEUVANCE 1
90677 Pneumococcal conjugate vaccine, 20 valent (PCV20), for IM use Pfizer Prevnar 20 1
90713 Poliovirus vaccine (IPV), inactivated, for SQ or IM use SP IPOL 1
90680 Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use Merck RotaTeq 1
90681 Rotavirus vaccine, human, atetanus toxoidsenuated (RV1), 2 dose GSK ROTARIX 1
schedule, live, for oral use
90714 Tetanus and diphtheria toxoids (Td) adsorbed, preservative free, MBL TDVAX 2
when administered to seven years or older, for IM use SP TENIVAC
90715 Tetanus, diphtheria toxoids and acellular pertussis SP Adacel 3
vaccine (Tdap), when administered to 7 years or older, GSK Boostrix
for IM use
90622 Vaccinia (smallpox) virus vaccine, live, lyophilized, 0.3 mL dosage, SP ACAM2000 1
percutaneous
90611 Smallpox and mpox vaccine, atetanus toxoidsenuated vaccinia virus, live, Jynneos Imvamune or Imvanex 2
non-replicating, preserv free, 0.5 mL dosage, suspension, SUBQ
90716 Varicella virus vaccine (VAR), live, for subcutaneous use Merck Varivax 1
90749 Unlisted vaccine or toxoid Please see CPT manual
2024 - 2025
INFLUENZA VACCINE PRODUCTS
Please note that Flu Vaccine NDC’s change each season
CPT Descriptor Manufacturer Brand # of Components
90656 Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 Seqirus AFLURIA 1
mL dosage, for IM use GSK FLUARIX
GSK FLULAVAL
SP Fluzone
90657 Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for Seqirus AFLURIA 1
IM use SP Fluzone
90658 Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL Seqirus AFLURIA 1
dosage, for IM use SP Fluzone
90660 Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use Astrazeneca FluMist 1
90661 Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, Seqirus Flucelvax 1
subunit, preservative and antibiotic free, 0.5 mL dosage, for IM use
Vaccine Immunization Administration – Includes Counseling
Do not use with Covid-19 vaccines—see 90480 below
CPT Descriptor
90460 IA through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only
component of each vaccine or toxoid component administered (Do not report with 90471 or 90473)
+90461 IA through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each
additional vaccine or toxoid component administered
Vaccine Immunization Administration – without physician counseling on the day of administration)
Do not use with Covid-19 vaccines—see 90480 below
CPT Descriptor
90471 IA, one injected vaccine (Do not report with 90460 or 90473)
+90472 IA, each additional injected vaccine
90473 IA by intranasal/oral route; one vaccine (Do not report with 90460 or 90471)
+90474 IA by intranasal/oral route; each additional vaccine
2024 – 2025
COVID-19 VACCINE PRODUCTS
ICD-10 Z23 (see below)
CPT Descriptor Manufacturer Brand # of Components
91319 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pfizer N/A 1
(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 10
mcg/0.3 mL dosage, tris-sucrose formulation, for IM use
91320 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pfizer Comirnaty 1
(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike
protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for IM
use
91321 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Moderna N/A 1
(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 25
mcg/0.25 mL dosage, for IM use
91322 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Moderna Spikevax 1
(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, 50 mcg/0.5 mL
dosage, for IM use
91304 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Novavax N/A 1
(coronavirus disease [COVID-19]) vaccine, recombinant spike protein
nanoparticle, saponin-based adjuvant, 5 mcg/0.5 mL dosage, for IM use
COVID-19 Vaccine Administration – Includes Counseling
CPT Descriptor
90480 Immunization administration by IM injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19])
vaccine, single dose
Monoclonal Antibodies for RSV
CPT Descriptor Manufacturer Brand # of Components
90378 Respiratory syncytial virus, monoclonal antibody, recombinant, SOBI Synagis 1
for IM use, 50 mg, each
90380 Respiratory syncytial virus, monoclonal antibody, seasonal dose; SP Beyfortus 1
0.5 mL dosage, for IM use
90381 Respiratory syncytial virus, monoclonal antibody, seasonal dose; SP Beyfortus 1
1 mL dosage, for IM use
Monoclonal Antibody Administration; Synagis
CPT Descriptor
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or IM
Monoclonal Antibody Administration; Beyfortus
CPT Descriptor
96380 Administration of respiratory syncytial virus, monoclonal antibody, seasonal dose by IM injection, with counseling by physician or other qualified
health care professional
96381 Administration of respiratory syncytial virus, monoclonal antibody, seasonal dose by IM injection (without physician/QHP counseling on the day of
administration)
Vaccine Diagnosis
Report with product and administration codes
ICD-10 Descriptor
Z23 Encounter for immunization
Monoclonal Antibodies Diagnosis Codes
Report with product and administration
ICD-10 Descriptor
Z29.11 Encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV)-Report only with Beyfortus
report any condition code that supports the need for Synagis, Z29.11 does not apply
Abbreviations: SP: Sanofi Pasteur, GSK: GlaxoSmithKline; IM: IM ; TETANUS TOXOIDS; tetanus toxoids; Severe acute respiratory syndrome coronavirus 2; SARS- CoV-2, QHP:
qualified healthcare professional (RN or PA)
Do Not Report Z23 for RSV Monoclonal Antibody Beyfortus; instead, report Z29.11 Encounter for prophylactic immunotherapy for respiratory syncytial
virus (RSV) and any condition that puts the patient at risk for RSV.
Vaccine pending FDA approval
+Denotes add-on code. Report code only with appropriate primary procedure. When multiple vaccines are administered, the administration type may differ based on
counseling was performed by physician/QHP on the date of administration, or route of administration IM or intranasal/oral route. Each immunization should have a
separate administration code (s) reported.
Immunization counseling must be performed by a physician or other qualified healthcare professional (eg, nurse practitioner or physician assistant), on the date of
product administration. Immunization counseling by clinical staff (eg, RN) is insufficient for these codes.
For information on pricing and National Drug Codes, please visit https://www.cdc.gov/vaccines-for-children/php/awardees/current-cdc-vaccine-price-
list.html?CDC_AAref_Val=htetanus toxoidsps://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html
Developed and maintained by the American Academy of Pediatrics. For reporting purposes only. The AAP makes every effort to ensure this information is
updated; however, vaccine changes may occur more frequently than updates are made.
CPT® Copyright 2024 American Medical Association. All rights reserved.
